X

Vous n'êtes pas connecté

Maroc Maroc - DRUGS.COM - Daily MedNews - 22/Aug 18:40

FDA Approves Updated COVID Shots for Fall

THURSDAY, Aug. 22, 2024 -- Updated shots to shield against COVID-19 infection were approved by the U.S. Food and Drug Administration on Thursday.This year's approval for the updated mRNA vaccines comes much sooner than happened in 2023, when fall...

Articles similaires

Sorry! Image not available at this time

FDA Approves Orlynvah (sulopenem etzadroxil and probenecid) for the Treatment of Uncomplicated Urinary Tract Infections

drugs.com - 25/Oct 21:10

DUBLIN and CHICAGO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (Iterum), today announced that the U.S. Food and Drug...

Sorry! Image not available at this time

U.S. FDA Approves Pfizer’s RSV Vaccine Abrysvo for Adults Aged 18 to 59 at Increased Risk for Disease

drugs.com - 22/Oct 05:10

NEW YORK--(BUSINESS WIRE) October 22, 2024 -- Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved...

Sorry! Image not available at this time

FDA Approves Vyalev for Advanced Parkinson Disease

drugs.com - 22/Oct 22:45

TUESDAY, Oct. 22, 2024 -- The U.S. Food and Drug Administration has approved Vyalev (foscarbidopa and foslevodopa) for adults living with advanced...

Sorry! Image not available at this time

FDA Approves Vyloy for Advanced Gastric or Gastroesophageal Junction Cancer

drugs.com - 23/Oct 14:10

WEDNESDAY, Oct. 23, 2024 -- The U.S. Food and Drug Administration has approved Vyloy (zolbetuximab-clzb) in combination with fluoropyrimidine- and...

Sorry! Image not available at this time

Monthly News Roundup - October 2024

drugs.com - 31/Oct 00:10

FDA Approves AbbVie’s Vyalev to Treat Advanced Parkinson Disease In October, the US Food and Drug Administration (FDA) approved Vyalev...

Sorry! Image not available at this time

Shorla Oncology Announces U.S. FDA Expanded Approval of Jylamvo (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications

drugs.com - 29/Oct 10:10

CAMBRIDGE, Mass.--(BUSINESS WIRE) October 29, 2024 --Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company,...

Sorry! Image not available at this time

Check Your Cabinet: Some COVID Test Expiration Dates Have Been Extended, FDA Says

drugs.com - 31/Oct 10:10

THURSDAY, Oct. 31, 2024 -- Don’t automatically throw out that old COVID-19 at-home test you just came across in your medicine cabinet. It might...

Sorry! Image not available at this time

Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of Selarsdi (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara (ustekinumab)

drugs.com - 22/Oct 04:10

REYKJAVIK, Iceland & PARSIPPANY, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of...

Sorry! Image not available at this time

FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent

drugs.com - 24/Oct 03:10

Melbourne (Australia) | 24 October 2024 -- Telix today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New...

Sorry! Image not available at this time

Abeona Therapeutics Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration

drugs.com - 29/Oct 22:10

CLEVELAND, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company has resubmitted its Biologics...